Dublin, Oct. 01, 2025 (GLOBE NEWSWIRE) -- The "Pharmaceutical Vials Market Industry Trends and Global Forecasts to 2035: Distribution by Type of Fabrication Material Used, Sterilization Status, and ...

President Donald J. Trump has signed an executive order that seeks to do what past presidents, including Trump himself in his previous administration, did not succeed in doing: increasing US ...

Section 1. Purpose. During my first term, my Administration acted to protect the health and security of the American people by restoring capacity for domestic production of essential pharmaceutical ...

President Donald Trump took on Big Pharma Monday with an executive order that will reduce the prices for prescriptions. The president said the U.S. “will no longer tolerate profiteering and price ...

PROMOTING AMERICAN-MADE PRESCRIPTION DRUGS: Today, President Donald J. Trump signed an Executive Order to facilitate the restoration of a robust domestic manufacturing base for prescription drugs, ...

Linde Material Handling has held its Automation Summit in Germany where it has launched its Robotic Case Picker (RoCaP), a ...

Get ready to rumble. In one corner, it’s President Donald Trump. In the other, it’s the pharmaceutical industry. Monday, Trump signed a sweeping executive order that he says will cut the price of ...

Trump's executive order aims to reduce U.S. drug prices by aligning them with international rates, potentially cutting costs by 30% to 80%. The order targets pharmacy benefit managers (PBMs) and seeks ...

FILE - Pharmaceuticals are seen in North Andover, Mass., on June 15, 2018. President Donald Trump's plan to change the pricing model for some medications is facing fierce criticism from the ...

President Donald Trump declared Monday that the U.S. "will no longer tolerate profiteering and price gouging from Big Pharma" as he signed an executive order implementing what his administration is ...

In President Donald Trump’s latest push to bring pharmaceutical manufacturing to the U.S., a new executive order tasks the FDA with reducing regulatory hurdles for domestic producers while making life ...